Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the Additional Roles Reimbursement Scheme on recruitment for community pharmacies.

The NHS Long Term Workforce Plan (LTWP), backed by over £2.4 billion to fund additional education and training places over the next five years, sets out the steps the National Health Service and education providers need to take to deliver an NHS workforce that meets the changing needs of the population over the next 15 years. The ambition is to increase training places for pharmacists by nearly 50% to around 5,000 by 2031/32, and to grow the number of pharmacy technicians.

The LTWP also commits to extend the success of the Additional Roles Reimbursement Scheme, which has delivered an additional 29,000 multi-professional roles in primary care. This expansion will consider the additional capacity required to staff roles across primary

TARGET DATE 18/07/2023

care, including community pharmacy. NHS England have committed to undertake and publish a review of the scheme by the end of 2023.

Overseas pharmacy professionals must meet the same standards as United Kingdom pharmacy professionals. The General Pharmaceutical Council has recently written to accredited educational providers to highlight the demand for places from overseas professionals and students, and a limited number of additional places have been created.

The Community Pharmacy Contractual Framework (CPCF) 2019-24 five-year deal ends at the end of March 2024. We are currently consulting Community Pharmacy England on the implementation of the pharmacy proposals in the delivery plan for recovering access to primary care. The funding for those proposals covers 2023/24 and 2024/25. There are regular discussions with NHS England about NHS funding. No discussions have been had with Community Pharmacy England about CPCF funding from March 2024.